Record date for final dividend

Pat Growth 25pctResults View source PDF Explain this filing

ANTHEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.1%Reaction day

₹780.00

prior close

₹801.00

announcement price

After-mkt

timing

Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)+0.4%-0.4% vs market

Pharmaceuticals & Biotechnology peers, median of 162sector · industry level+0.3%-0.4% vs sector

On the reaction day the stock moved 0.4 pts less than Nifty Midcap 150 and 0.4 pts less than its Pharmaceuticals & Biotechnology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.2

10m

+1.0

15m

+0.8

30m

+0.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.1+0.4-0.4+0.3-0.4

Next day

-1.3+0.5-1.8+0.7-2.0

-0.5+0.6-1.1+0.4-1.0

-2.2+1.4-3.7+1.7-3.9

-1.3+1.9-3.1+1.8-3.1

-3.0+2.3-5.3+2.0-5.0

-3.8-0.5-3.4+1.3-5.1

15d

+0.0-2.9+2.9-0.6+0.6

-1.7+3.1-4.8+3.8-5.4

+1.2+3.2-2.0+7.8-6.6

+12.2+4.5+7.6+8.2+3.9

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals & Biotechnology peers, median of 162Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Anthem Biosciences Board approved FY2026 results with standalone revenue of Rs 2,089 crore (up 13.5%) and consolidated revenue of Rs 2,120 crore (up 15%). Standalone PAT grew 27% to Rs 570 crore while consolidated PAT grew 31% to Rs 592 crore. The Board recommended a final dividend of Rs 2 per share (100% payout on face value), with record date June 26, 2026. The company also allotted 14.81 lakh equity shares under ESOP 2024. Auditors issued unmodified opinion on both standalone and consolidated financials.

Likely market impact

Strong financial performance with PAT growth exceeding 25% signals positive sentiment for shareholders. The dividend recommendation provides immediate return opportunity with record date set for late June.